Research study Program year 2021 Source: CMS Open Payments

Adaptive Pan Malignancy Study for indications in which there is no approved immunomodulating therapy or BMS registration pathway

Research payments

$28,933

14 payments

Through program year 2021, $28,933 in research payments was reported against Adaptive Pan Malignancy Study for indications in which there is no approved immunomodulating therapy or BMS registration pathway, across 14 payments, paid by E.R. Squibb & Sons, L.L.C..

Paid by
E.R. Squibb & Sons, L.L.C.
ClinicalTrials.gov
No trial number was reported for this study

By program year

3 rows
Year Kind Amount Payments
2021 Research $26,693 1
2020 Research $104 1
2019 Research $2,136 12

Breakdown

Who paid Research payments · program years 2019–2021
  1. E.R. Squibb & Sons, L.L.C. $28,933 14 payments
Who received the money Research payments · program years 2019–2021
  1. Langley Porter Psychiatric Hospital Teaching hospital · CA $26,693 1 payment
  2. Tennessee Oncology Organisation paid for research $921 1 payment
  3. University Of Texas MD Anderson Cancer Center Organisation paid for research $327 1 payment
  4. Florida Cancer Specialists & Research Institute Organisation paid for research $235 3 payments
  5. Florida Cancer Specialist- West Palm Beach Organisation paid for research $233 2 payments
  6. Saint Jude Hospital Yorba Linda Organisation paid for research $171 1 payment
  7. Cbcc Global Research, Incorporated Organisation paid for research $134 1 payment
  8. Research Medical Center Organisation paid for research $82 1 payment
  9. Ucla Main Campus - University California Los Angeles Organisation paid for research $80 1 payment
  10. Central Coast Medical Oncology Corporation Organisation paid for research $46 1 payment

Usually the institution or organisation running the study, not a person.

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

9 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record